球盟会

Home > Ind News

The Blue Book predicts that my country's medical device market revenue will exceed one trillion: the next decade is still a golden period of development

Today, under the resonance of the three factors of market, technology and policy dividends, domestic medical devices have gradually embarked on the road of high-quality development. From 2021 to 2022, the main operating income of medical device manufacturers is expected to exceed one trillion yuan. Recently, the ``Medical Device Blue Book: China's Medical Device Industry Development Report (2019)'' jointly issued by the China Pharmaceutical Regulatory and Research Institute and the Social Sciences Literature Press pointed out that although my country's medical device industry R&D investment is significantly biased compared with multinational medical device companies Low, but the next ten years will still be the "golden period" of rapid development.

The medical device field ushered in an outbreak period but still lacks industry competitiveness

The Blue Book pointed out that in 2018, my country's exports of medical device products to countries along the "Belt and Road" reached 4.963 billion U.S. dollars, accounting for about 20% of my country's total exports, a year-on-year increase of 10.89%, of which the growth rate of medical equipment and health rehabilitation products was significant. , Respectively 13.01% and 13.09%.

Although China has certain medical device manufacturing capabilities, there are still structural gaps in medical device products. Wang Baoting, deputy secretary-general of the Chinese Society for Drug Administration and Chairman of the Medical Device Regulatory Research Professional Committee, cited as an example, the gap in technology, materials, equipment and process levels, the lack of new concepts led by independent innovation technology, and the difficulty of manufacturing compliance The high value-added new products of medical technology trend, and some key core component technologies have not yet been completely overcome.

"The degree of specialization in some sub-fields needs to be improved, and some industrial structures are too fragmented. At the same time, high-end manufacturing equipment and product quality testing instruments rely on imports and lack the right to speak in the advanced medical device market." Wang Baoting said.

The Blue Book pointed out that more than 90% of medical device manufacturers are small and medium-sized enterprises, with an average annual revenue of 30-40 million yuan. Compared with the 300-400 million yuan of domestic pharmaceutical companies, there is still a huge gap.

The data shows that from 2008 to 2018, the number of Type I and Type II production companies increased rapidly, with compound annual growth rates of 6.8% and 2.4%, respectively. Among them, the number of Type I production companies has grown the most rapidly, and the number of Type III production companies has shown rapid growth in the past four years. The downward trend, the compound annual growth rate is -0.3%.

According to Wang Baoting's analysis, it is mainly because of the lower technical requirements and small capital needs of the first and second types of medical device companies, while the third type of medical device companies have high technical requirements and large capital needs; since 2014, medical device supervision has become stricter and more accurate. Higher and higher entry standards are also important reasons.

According to the report, medical device production and operation companies are “many, small, and low”, industry R&D investment is significantly lower than that of multinational medical device companies, and most of the high-end medical device market is occupied by multinational companies. The situation has not changed significantly. Medical device supervision The problem of relative lack of strength still exists.

The next ten years will still be the "golden period" for the rapid development of my country's medical device industry

With the gradual establishment of my country's legal environment and the rapid growth of the industry, my country's medical device market has become the second largest market in the world. According to industry research data, the compound growth rate of China's medical device industry continues to remain at about 15%. Last year, data from the Ministry of Industry and Information Technology showed that the industry growth rate was 14.45%. Blue Book analysis believes that in 2018, the main operating income of Chinese medical device manufacturers is about 638 billion yuan. By 2021 to 2022, the main operating income of medical device manufacturers is expected to exceed one trillion yuan.





2016-2022 my country's medical device manufacturers' main revenue forecast (Photo courtesy of Social Science Literature Press)

The rapid growth of the medical device industry is also inseparable from the gradual improvement of industry policies. In recent years, the National Medical Products Administration has formulated a series of documents to encourage the development of innovative medical devices. While deepening the reform of the review and approval system, it also pays more attention to the supervision of medical devices after the market to ensure the safety and effectiveness of the public's use of devices.

At the same time, in order to control the excessive growth of medical expenses, the medical insurance department has proposed a series of practical medical insurance mechanism reform ideas, and the curtain of payment by disease and diagnosis related groups (DRGs, Diagnosis Related Groups) has also begun. . Drawing lessons from the reform achievements in the medical field, in the management of large-scale medical equipment and high-value medical consumables, we will carry out centralized procurement of large-scale medical equipment and medical high-value consumables, adopt the "two-invoice system", implement the "zero price difference", and explore the distribution mechanism of "surplus retention and reasonable sharing of overspending", The implementation of medical insurance payment prices has become the focus of the future "three-medicine linkage" reform.

Wang Baoting said bluntly that the mergers, unions, and reorganizations of my country's medical device production and operation enterprises will be more common and frequent, and the scale of enterprises, especially the scale of large enterprises, will accelerate. "Medical imaging products, in vitro diagnostic products, implant products, and home medical device products in the medical device industry will develop at a faster rate, especially AI smart medical devices will quickly rise." He said.

In terms of talent training, the Blue Book specifically pointed out that China's talent team engaged in medical device research and development has continued to grow and grow. A large number of high-end talents who have returned from overseas have joined key medical device companies one after another, and their innovative research and development capabilities have been continuously improved. Combining the above development results, the Blue Book believes that in the near future, China will become the world's largest medical device market, and the medical device industry will continue to maintain a good momentum of rapid and healthy development. The next ten years will still be a golden period for the rapid development of China's medical device industry.

Previous:The Yangtze River Delta Medical Device Registrant System Launches Pilot

Next:Look at the changes in our country's medical device industry

Add: No.898 Yaocheng Road,Medical Hi-tech Zone,Taizhou,Jiangsu,China Cellphones: +86-13810890388 Technical Support: Zecheng Network


Keywords:Electric Dermatome Skin Graft Mesher Skin Grafting Multi-use Machine Skin Graft Carrier Micro-skin Cutter Granular Skin Cutter Burn and Plastic Surgery
Cosmetic Surgery


球盟会